Studies show weight may return at about 0.4 kg (almost 1 lb) per month after stopping
In short, GLP-1s shouldnt be used as a quick-fix in order to lose a few pounds, but rather for patients in whom the risk-benefit profile makes sensein obese individuals at a high risk of developing additional CIDs, for example, in whom the use of GLP-1s seems less concerning than the risks associated with a lifetime of severe weight issues
Research published in the journal Diabetes, Obesity and Metabolism documented significant decreases in serum B12 levels in patients taking once-weekly semaglutide, alongside drops in zinc and albumin
Diabetes Care, 42(12), 22722281
Nasseri will also provide detailed instructions on how to administer these medications, their potential side effects, and their proper storage and handling